Structure

Physi-Chem Properties

Molecular Weight:  600.33
Volume:  628.971
LogP:  4.837
LogD:  2.55
LogS:  -4.591
# Rotatable Bonds:  16
TPSA:  128.59
# H-Bond Aceptor:  9
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.073
Synthetic Accessibility Score:  5.995
Fsp3:  0.618
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.886
MDCK Permeability:  4.120222001802176e-05
Pgp-inhibitor:  0.971
Pgp-substrate:  0.983
Human Intestinal Absorption (HIA):  0.03
20% Bioavailability (F20%):  0.919
30% Bioavailability (F30%):  0.704

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.196
Plasma Protein Binding (PPB):  87.81970977783203%
Volume Distribution (VD):  1.915
Pgp-substrate:  6.345552921295166%

ADMET: Metabolism

CYP1A2-inhibitor:  0.056
CYP1A2-substrate:  0.069
CYP2C19-inhibitor:  0.072
CYP2C19-substrate:  0.275
CYP2C9-inhibitor:  0.566
CYP2C9-substrate:  0.194
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.068
CYP3A4-inhibitor:  0.736
CYP3A4-substrate:  0.325

ADMET: Excretion

Clearance (CL):  2.753
Half-life (T1/2):  0.141

ADMET: Toxicity

hERG Blockers:  0.564
Human Hepatotoxicity (H-HT):  0.953
Drug-inuced Liver Injury (DILI):  0.876
AMES Toxicity:  0.59
Rat Oral Acute Toxicity:  0.922
Maximum Recommended Daily Dose:  0.975
Skin Sensitization:  0.949
Carcinogencity:  0.301
Eye Corrosion:  0.004
Eye Irritation:  0.012
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC317460

Natural Product ID:  NPC317460
Common Name*:   Casearupestrin B
IUPAC Name:   [(1R,3R,5R,6aS,7S,8S,9R,10R,10aS)-1,3-diacetyloxy-5,10-dihydroxy-7,8-dimethyl-7-(3-methylidenepent-4-enyl)-1,3,5,6,6a,8,9,10-octahydrobenzo[d][2]benzofuran-9-yl] (2Z,4E)-deca-2,4-dienoate
Synonyms:   casearupestrin B
Standard InCHIKey:  WGHDGSZCVSIZQE-WWRGVMLBSA-N
Standard InCHI:  InChI=1S/C34H48O9/c1-8-10-11-12-13-14-15-16-28(38)42-29-22(4)33(7,18-17-21(3)9-2)27-20-25(37)19-26-31(40-23(5)35)43-32(41-24(6)36)34(26,27)30(29)39/h9,13-16,19,22,25,27,29-32,37,39H,2-3,8,10-12,17-18,20H2,1,4-7H3/b14-13+,16-15-/t22-,25+,27+,29-,30+,31+,32+,33-,34-/m1/s1
SMILES:  CCCCCC=CC=CC(=O)OC1C(C(C2CC(C=C3C2(C1O)C(OC3OC(=O)C)OC(=O)C)O)(C)CCC(=C)C=C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1774418
PubChem CID:   52951397
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO2718 Casearia rupestris Species Salicaceae Eukaryota leaves n.a. n.a. PMID[21381705]
NPO2718 Casearia rupestris Species Salicaceae Eukaryota n.a. leaf n.a. PMID[21381705]
NPO2718 Casearia rupestris Species Salicaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 = 850.0 nM PMID[560362]
NPT400 Cell Line MDA-MB-435 Homo sapiens IC50 = 1300.0 nM PMID[560362]
NPT180 Cell Line HCT-8 Homo sapiens IC50 = 280.0 nM PMID[560362]
NPT399 Cell Line SF-295 Homo sapiens IC50 = 800.0 nM PMID[560362]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC317460 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470025
1.0 High Similarity NPC328074
1.0 High Similarity NPC321272
0.9904 High Similarity NPC470027
0.9903 High Similarity NPC17791
0.9806 High Similarity NPC316708
0.9712 High Similarity NPC470026
0.9612 High Similarity NPC470024
0.9515 High Similarity NPC109376
0.9423 High Similarity NPC224660
0.9417 High Similarity NPC172867
0.9333 High Similarity NPC40728
0.9333 High Similarity NPC316974
0.9238 High Similarity NPC217921
0.9238 High Similarity NPC311223
0.9238 High Similarity NPC128795
0.9238 High Similarity NPC135015
0.9238 High Similarity NPC48548
0.9143 High Similarity NPC88013
0.9143 High Similarity NPC125423
0.9065 High Similarity NPC119550
0.9048 High Similarity NPC218158
0.8952 High Similarity NPC81567
0.8952 High Similarity NPC264867
0.8952 High Similarity NPC470321
0.8952 High Similarity NPC201880
0.8952 High Similarity NPC473207
0.8857 High Similarity NPC7613
0.8857 High Similarity NPC134270
0.8857 High Similarity NPC127933
0.8857 High Similarity NPC7644
0.8857 High Similarity NPC475889
0.8796 High Similarity NPC206618
0.8785 High Similarity NPC184512
0.8762 High Similarity NPC471363
0.8762 High Similarity NPC238397
0.8761 High Similarity NPC470914
0.8738 High Similarity NPC98112
0.8716 High Similarity NPC177047
0.8704 High Similarity NPC38948
0.8692 High Similarity NPC82251
0.8692 High Similarity NPC252296
0.8649 High Similarity NPC264153
0.8649 High Similarity NPC473159
0.8641 High Similarity NPC171598
0.8611 High Similarity NPC472390
0.8598 High Similarity NPC470768
0.8585 High Similarity NPC11956
0.8571 High Similarity NPC473204
0.8571 High Similarity NPC473545
0.8571 High Similarity NPC472187
0.8544 High Similarity NPC472189
0.8544 High Similarity NPC471362
0.8544 High Similarity NPC471372
0.8534 High Similarity NPC471082
0.8519 High Similarity NPC470763
0.8519 High Similarity NPC470767
0.8519 High Similarity NPC239961
0.8509 High Similarity NPC473617
0.8509 High Similarity NPC473828
0.8505 High Similarity NPC281378
0.8505 High Similarity NPC23584
0.8491 Intermediate Similarity NPC198992
0.8491 Intermediate Similarity NPC472554
0.8476 Intermediate Similarity NPC471366
0.8476 Intermediate Similarity NPC476800
0.8476 Intermediate Similarity NPC472186
0.8476 Intermediate Similarity NPC318917
0.8448 Intermediate Similarity NPC233500
0.8435 Intermediate Similarity NPC219656
0.8421 Intermediate Similarity NPC23046
0.8421 Intermediate Similarity NPC473968
0.8411 Intermediate Similarity NPC201191
0.8411 Intermediate Similarity NPC470571
0.8411 Intermediate Similarity NPC472815
0.8411 Intermediate Similarity NPC150463
0.8411 Intermediate Similarity NPC472552
0.8393 Intermediate Similarity NPC473125
0.8381 Intermediate Similarity NPC472188
0.8376 Intermediate Similarity NPC196130
0.8364 Intermediate Similarity NPC475263
0.8364 Intermediate Similarity NPC50124
0.8362 Intermediate Similarity NPC48692
0.8348 Intermediate Similarity NPC470515
0.8333 Intermediate Similarity NPC207637
0.8333 Intermediate Similarity NPC474124
0.8333 Intermediate Similarity NPC120009
0.8333 Intermediate Similarity NPC474575
0.8319 Intermediate Similarity NPC49413
0.8319 Intermediate Similarity NPC40133
0.8319 Intermediate Similarity NPC44298
0.8319 Intermediate Similarity NPC473128
0.8319 Intermediate Similarity NPC290608
0.8318 Intermediate Similarity NPC280991
0.8305 Intermediate Similarity NPC219804
0.8302 Intermediate Similarity NPC474440
0.8291 Intermediate Similarity NPC476204
0.8291 Intermediate Similarity NPC170084
0.8288 Intermediate Similarity NPC475586
0.8276 Intermediate Similarity NPC470911
0.8276 Intermediate Similarity NPC470517
0.8276 Intermediate Similarity NPC470915
0.8276 Intermediate Similarity NPC122971
0.8273 Intermediate Similarity NPC122816
0.8273 Intermediate Similarity NPC475074
0.8273 Intermediate Similarity NPC473586
0.8273 Intermediate Similarity NPC471205
0.8269 Intermediate Similarity NPC469491
0.8261 Intermediate Similarity NPC203862
0.8257 Intermediate Similarity NPC473543
0.8246 Intermediate Similarity NPC475163
0.8241 Intermediate Similarity NPC476471
0.8241 Intermediate Similarity NPC214277
0.8241 Intermediate Similarity NPC475344
0.8241 Intermediate Similarity NPC121423
0.823 Intermediate Similarity NPC231797
0.8224 Intermediate Similarity NPC324841
0.8224 Intermediate Similarity NPC64348
0.8224 Intermediate Similarity NPC477972
0.8224 Intermediate Similarity NPC161527
0.8224 Intermediate Similarity NPC38855
0.8224 Intermediate Similarity NPC219285
0.8224 Intermediate Similarity NPC228251
0.8224 Intermediate Similarity NPC477971
0.8224 Intermediate Similarity NPC20113
0.8224 Intermediate Similarity NPC477968
0.8214 Intermediate Similarity NPC235014
0.8208 Intermediate Similarity NPC91197
0.8208 Intermediate Similarity NPC125551
0.8208 Intermediate Similarity NPC96597
0.8208 Intermediate Similarity NPC239547
0.8208 Intermediate Similarity NPC309503
0.8208 Intermediate Similarity NPC120446
0.8208 Intermediate Similarity NPC155319
0.8205 Intermediate Similarity NPC135369
0.8198 Intermediate Similarity NPC181994
0.819 Intermediate Similarity NPC234522
0.819 Intermediate Similarity NPC275310
0.819 Intermediate Similarity NPC230347
0.819 Intermediate Similarity NPC286612
0.8182 Intermediate Similarity NPC470056
0.8182 Intermediate Similarity NPC51719
0.8182 Intermediate Similarity NPC88349
0.8182 Intermediate Similarity NPC470055
0.8174 Intermediate Similarity NPC471816
0.8167 Intermediate Similarity NPC179261
0.8165 Intermediate Similarity NPC473523
0.8165 Intermediate Similarity NPC45897
0.8165 Intermediate Similarity NPC473070
0.8158 Intermediate Similarity NPC474410
0.8158 Intermediate Similarity NPC469496
0.8158 Intermediate Similarity NPC469463
0.8158 Intermediate Similarity NPC469454
0.8158 Intermediate Similarity NPC287075
0.8158 Intermediate Similarity NPC293658
0.8155 Intermediate Similarity NPC469403
0.8155 Intermediate Similarity NPC470817
0.8151 Intermediate Similarity NPC41129
0.8148 Intermediate Similarity NPC475617
0.8142 Intermediate Similarity NPC208189
0.8142 Intermediate Similarity NPC65034
0.8136 Intermediate Similarity NPC202051
0.8131 Intermediate Similarity NPC477928
0.8131 Intermediate Similarity NPC473154
0.8125 Intermediate Similarity NPC257853
0.812 Intermediate Similarity NPC44899
0.812 Intermediate Similarity NPC475775
0.812 Intermediate Similarity NPC29639
0.812 Intermediate Similarity NPC304260
0.812 Intermediate Similarity NPC5883
0.812 Intermediate Similarity NPC268326
0.812 Intermediate Similarity NPC153085
0.812 Intermediate Similarity NPC476529
0.8115 Intermediate Similarity NPC476966
0.8115 Intermediate Similarity NPC471407
0.8113 Intermediate Similarity NPC284194
0.8113 Intermediate Similarity NPC165632
0.8113 Intermediate Similarity NPC221801
0.8113 Intermediate Similarity NPC211810
0.8113 Intermediate Similarity NPC471765
0.8113 Intermediate Similarity NPC473153
0.8108 Intermediate Similarity NPC293512
0.8108 Intermediate Similarity NPC33053
0.8103 Intermediate Similarity NPC93883
0.8103 Intermediate Similarity NPC474483
0.8103 Intermediate Similarity NPC152615
0.8095 Intermediate Similarity NPC256368
0.8095 Intermediate Similarity NPC88507
0.8095 Intermediate Similarity NPC472360
0.8095 Intermediate Similarity NPC470255
0.8095 Intermediate Similarity NPC472416
0.8091 Intermediate Similarity NPC85593
0.8091 Intermediate Similarity NPC75608
0.8091 Intermediate Similarity NPC93352
0.8091 Intermediate Similarity NPC473068
0.8091 Intermediate Similarity NPC194941
0.8091 Intermediate Similarity NPC31430
0.8087 Intermediate Similarity NPC181145
0.8083 Intermediate Similarity NPC469379
0.8083 Intermediate Similarity NPC471090

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC317460 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8291 Intermediate Similarity NPD7503 Approved
0.8036 Intermediate Similarity NPD6686 Approved
0.7983 Intermediate Similarity NPD8033 Approved
0.7966 Intermediate Similarity NPD7516 Approved
0.7899 Intermediate Similarity NPD8377 Approved
0.7899 Intermediate Similarity NPD8294 Approved
0.7881 Intermediate Similarity NPD7327 Approved
0.7881 Intermediate Similarity NPD7328 Approved
0.7833 Intermediate Similarity NPD8378 Approved
0.7833 Intermediate Similarity NPD8296 Approved
0.7833 Intermediate Similarity NPD8335 Approved
0.7833 Intermediate Similarity NPD8379 Approved
0.7833 Intermediate Similarity NPD8380 Approved
0.7818 Intermediate Similarity NPD5344 Discontinued
0.7798 Intermediate Similarity NPD4225 Approved
0.7727 Intermediate Similarity NPD6648 Approved
0.7686 Intermediate Similarity NPD8516 Approved
0.7686 Intermediate Similarity NPD8515 Approved
0.7686 Intermediate Similarity NPD8513 Phase 3
0.7686 Intermediate Similarity NPD8517 Approved
0.7642 Intermediate Similarity NPD7838 Discovery
0.7636 Intermediate Similarity NPD8029 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD7507 Approved
0.7411 Intermediate Similarity NPD7639 Approved
0.7411 Intermediate Similarity NPD7640 Approved
0.735 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD7638 Approved
0.7266 Intermediate Similarity NPD7319 Approved
0.7238 Intermediate Similarity NPD6400 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD7115 Discovery
0.7203 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7736 Approved
0.7179 Intermediate Similarity NPD6412 Phase 2
0.7143 Intermediate Similarity NPD8328 Phase 3
0.7109 Intermediate Similarity NPD8074 Phase 3
0.7107 Intermediate Similarity NPD8133 Approved
0.7063 Intermediate Similarity NPD6370 Approved
0.7 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.6977 Remote Similarity NPD8293 Discontinued
0.6953 Remote Similarity NPD7492 Approved
0.6942 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6935 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6905 Remote Similarity NPD6054 Approved
0.6899 Remote Similarity NPD6616 Approved
0.6885 Remote Similarity NPD8297 Approved
0.6885 Remote Similarity NPD6882 Approved
0.6881 Remote Similarity NPD7524 Approved
0.6847 Remote Similarity NPD46 Approved
0.6847 Remote Similarity NPD6698 Approved
0.6846 Remote Similarity NPD7078 Approved
0.6838 Remote Similarity NPD7632 Discontinued
0.68 Remote Similarity NPD6009 Approved
0.6786 Remote Similarity NPD7637 Suspended
0.6786 Remote Similarity NPD7983 Approved
0.6772 Remote Similarity NPD6319 Approved
0.675 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6726 Remote Similarity NPD5778 Approved
0.6726 Remote Similarity NPD5779 Approved
0.6719 Remote Similarity NPD6015 Approved
0.6719 Remote Similarity NPD6016 Approved
0.6694 Remote Similarity NPD4632 Approved
0.6667 Remote Similarity NPD5988 Approved
0.6641 Remote Similarity NPD6059 Approved
0.6615 Remote Similarity NPD6067 Discontinued
0.6615 Remote Similarity NPD7830 Approved
0.6615 Remote Similarity NPD7829 Approved
0.6612 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6606 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6585 Remote Similarity NPD6371 Approved
0.6557 Remote Similarity NPD6881 Approved
0.6557 Remote Similarity NPD6899 Approved
0.6557 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6545 Remote Similarity NPD1694 Approved
0.6538 Remote Similarity NPD8264 Approved
0.6532 Remote Similarity NPD8130 Phase 1
0.6532 Remote Similarity NPD6650 Approved
0.6532 Remote Similarity NPD6649 Approved
0.6522 Remote Similarity NPD7748 Approved
0.6519 Remote Similarity NPD7260 Phase 2
0.6514 Remote Similarity NPD6695 Phase 3
0.6496 Remote Similarity NPD7902 Approved
0.6475 Remote Similarity NPD5697 Approved
0.6458 Remote Similarity NPD7625 Phase 1
0.6452 Remote Similarity NPD7290 Approved
0.6452 Remote Similarity NPD6883 Approved
0.6452 Remote Similarity NPD7102 Approved
0.6429 Remote Similarity NPD7750 Discontinued
0.6403 Remote Similarity NPD7966 Clinical (unspecified phase)
0.64 Remote Similarity NPD6847 Approved
0.64 Remote Similarity NPD6869 Approved
0.64 Remote Similarity NPD6617 Approved
0.6393 Remote Similarity NPD6402 Approved
0.6393 Remote Similarity NPD5739 Approved
0.6393 Remote Similarity NPD6675 Approved
0.6393 Remote Similarity NPD7128 Approved
0.6371 Remote Similarity NPD6014 Approved
0.6371 Remote Similarity NPD6012 Approved
0.6371 Remote Similarity NPD6372 Approved
0.6371 Remote Similarity NPD6373 Approved
0.6371 Remote Similarity NPD6013 Approved
0.6364 Remote Similarity NPD7604 Phase 2
0.6349 Remote Similarity NPD6053 Discontinued
0.6348 Remote Similarity NPD6411 Approved
0.6348 Remote Similarity NPD7515 Phase 2
0.6336 Remote Similarity NPD5983 Phase 2
0.6296 Remote Similarity NPD6929 Approved
0.6293 Remote Similarity NPD6399 Phase 3
0.629 Remote Similarity NPD6011 Approved
0.629 Remote Similarity NPD7320 Approved
0.6281 Remote Similarity NPD5211 Phase 2
0.6273 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6271 Remote Similarity NPD7839 Suspended
0.6269 Remote Similarity NPD6336 Discontinued
0.6269 Remote Similarity NPD8451 Approved
0.626 Remote Similarity NPD6008 Approved
0.625 Remote Similarity NPD7266 Discontinued
0.625 Remote Similarity NPD7799 Discontinued
0.6239 Remote Similarity NPD7900 Approved
0.6239 Remote Similarity NPD7332 Phase 2
0.6239 Remote Similarity NPD6931 Approved
0.6239 Remote Similarity NPD6930 Phase 2
0.6239 Remote Similarity NPD7514 Phase 3
0.6239 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6232 Remote Similarity NPD6845 Suspended
0.6231 Remote Similarity NPD7641 Discontinued
0.6222 Remote Similarity NPD8448 Approved
0.6212 Remote Similarity NPD8444 Approved
0.6211 Remote Similarity NPD8470 Clinical (unspecified phase)
0.621 Remote Similarity NPD5701 Approved
0.6207 Remote Similarity NPD6079 Approved
0.6204 Remote Similarity NPD7145 Approved
0.6194 Remote Similarity NPD8299 Approved
0.6194 Remote Similarity NPD8342 Approved
0.6194 Remote Similarity NPD8340 Approved
0.6194 Remote Similarity NPD8341 Approved
0.619 Remote Similarity NPD7274 Clinical (unspecified phase)
0.619 Remote Similarity NPD4634 Approved
0.6186 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6182 Remote Similarity NPD6902 Approved
0.6179 Remote Similarity NPD5141 Approved
0.6176 Remote Similarity NPD6033 Approved
0.6174 Remote Similarity NPD6101 Approved
0.6174 Remote Similarity NPD6051 Approved
0.6174 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6165 Remote Similarity NPD5126 Approved
0.6165 Remote Similarity NPD5125 Phase 3
0.6154 Remote Similarity NPD8171 Discontinued
0.6147 Remote Similarity NPD7645 Phase 2
0.614 Remote Similarity NPD4250 Approved
0.614 Remote Similarity NPD4251 Approved
0.6129 Remote Similarity NPD6640 Phase 3
0.6121 Remote Similarity NPD5785 Approved
0.6121 Remote Similarity NPD3168 Discontinued
0.6116 Remote Similarity NPD4696 Approved
0.6116 Remote Similarity NPD5285 Approved
0.6116 Remote Similarity NPD5286 Approved
0.6115 Remote Similarity NPD8449 Approved
0.6111 Remote Similarity NPD5776 Phase 2
0.6111 Remote Similarity NPD6925 Approved
0.6091 Remote Similarity NPD7525 Registered
0.609 Remote Similarity NPD6921 Approved
0.6087 Remote Similarity NPD8391 Approved
0.6087 Remote Similarity NPD8392 Approved
0.6087 Remote Similarity NPD8390 Approved
0.6083 Remote Similarity NPD6084 Phase 2
0.6083 Remote Similarity NPD6083 Phase 2
0.6071 Remote Similarity NPD8450 Suspended
0.6068 Remote Similarity NPD7087 Discontinued
0.6066 Remote Similarity NPD4159 Approved
0.6061 Remote Similarity NPD7100 Approved
0.6061 Remote Similarity NPD7101 Approved
0.6053 Remote Similarity NPD3618 Phase 1
0.6053 Remote Similarity NPD4249 Approved
0.6034 Remote Similarity NPD5328 Approved
0.6031 Remote Similarity NPD7505 Discontinued
0.6019 Remote Similarity NPD6933 Approved
0.6016 Remote Similarity NPD5225 Approved
0.6016 Remote Similarity NPD4633 Approved
0.6016 Remote Similarity NPD5226 Approved
0.6016 Remote Similarity NPD5224 Approved
0.6016 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6 Remote Similarity NPD4792 Clinical (unspecified phase)
0.6 Remote Similarity NPD7532 Clinical (unspecified phase)
0.6 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6 Remote Similarity NPD7642 Approved
0.6 Remote Similarity NPD5222 Approved
0.6 Remote Similarity NPD8338 Approved
0.6 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6 Remote Similarity NPD5221 Approved
0.5988 Remote Similarity NPD8407 Phase 2
0.5985 Remote Similarity NPD6335 Approved
0.5971 Remote Similarity NPD5956 Approved
0.5968 Remote Similarity NPD5174 Approved
0.5968 Remote Similarity NPD5175 Approved
0.5965 Remote Similarity NPD1696 Phase 3
0.5965 Remote Similarity NPD6893 Approved
0.5963 Remote Similarity NPD6932 Approved
0.5957 Remote Similarity NPD5952 Clinical (unspecified phase)
0.5954 Remote Similarity NPD6868 Approved
0.5954 Remote Similarity NPD6274 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data